1. Home
  2. LCFY vs EKSO Comparison

LCFY vs EKSO Comparison

Compare LCFY & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LCFY
  • EKSO
  • Stock Information
  • Founded
  • LCFY 2009
  • EKSO 2005
  • Country
  • LCFY Australia
  • EKSO United States
  • Employees
  • LCFY N/A
  • EKSO N/A
  • Industry
  • LCFY
  • EKSO Medical/Dental Instruments
  • Sector
  • LCFY
  • EKSO Health Care
  • Exchange
  • LCFY Nasdaq
  • EKSO Nasdaq
  • Market Cap
  • LCFY 9.2M
  • EKSO 7.7M
  • IPO Year
  • LCFY 2022
  • EKSO N/A
  • Fundamental
  • Price
  • LCFY $3.20
  • EKSO $4.32
  • Analyst Decision
  • LCFY
  • EKSO Strong Buy
  • Analyst Count
  • LCFY 0
  • EKSO 2
  • Target Price
  • LCFY N/A
  • EKSO $7.75
  • AVG Volume (30 Days)
  • LCFY 18.8K
  • EKSO 50.0K
  • Earning Date
  • LCFY 11-12-2025
  • EKSO 10-28-2025
  • Dividend Yield
  • LCFY N/A
  • EKSO N/A
  • EPS Growth
  • LCFY N/A
  • EKSO N/A
  • EPS
  • LCFY N/A
  • EKSO N/A
  • Revenue
  • LCFY $2,099,713.00
  • EKSO $14,749,000.00
  • Revenue This Year
  • LCFY N/A
  • EKSO N/A
  • Revenue Next Year
  • LCFY N/A
  • EKSO $49.96
  • P/E Ratio
  • LCFY N/A
  • EKSO N/A
  • Revenue Growth
  • LCFY N/A
  • EKSO N/A
  • 52 Week Low
  • LCFY $2.51
  • EKSO $2.73
  • 52 Week High
  • LCFY $13.98
  • EKSO $14.97
  • Technical
  • Relative Strength Index (RSI)
  • LCFY 21.46
  • EKSO 42.62
  • Support Level
  • LCFY $3.14
  • EKSO $3.86
  • Resistance Level
  • LCFY $3.80
  • EKSO $4.32
  • Average True Range (ATR)
  • LCFY 0.26
  • EKSO 0.40
  • MACD
  • LCFY -0.02
  • EKSO -0.11
  • Stochastic Oscillator
  • LCFY 7.69
  • EKSO 21.58

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.

About EKSO Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

Share on Social Networks: